Maria Margareta Pertl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Margareta Pertl has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- David Hevey
Trinity College Dublin, Ireland
9 shared publications - Agnella Craig
Applied Radiation Therapy Trinity, Discipline of Radiation Therapy, Trinity College Dublin, Dublin, Ireland.
5 shared publications - Kevin Thomas
Surgeon Wellbeing Research Team, School of Psychology, Poole House, Bournemouth University, Fern Barrow, Poole BH12 5BB, UK
5 shared publications - Frank Doyle
RCSI University of Medicine and Health Sciences, Dublin, Ireland
4 shared publications Sonya Collier
St James Hospital
4 shared publicationsL. Maher
Trinity College Dublin, Ireland
3 shared publications
Latest Publications
- 11 November 2026
- Published by Taylor & Francis in Aging & Mental Health
- p. 1-13
Sight loss is associated with worsening depressive and anxiety symptoms among older adults: evidence from the Irish longitudinal study on ageing
Sight loss is associated with adverse mental health conditions among aging populations. The extent of which sight loss worsens depression or anxiety in those with existing or at an elevated risk is unknown. This study aims to examine whether sight loss prospectively predicts progression/worsening of depression and anxiety. A longitudinal secondary analysis of The Irish Longitudinal Study of Ageing (TILDA) was conducted. Outcomes for anxiety and depression were measured through the self-reported Centre for Epidemiological Studies Depression Scale and the Hospital Anxiety and Depression-Anxiety subscale. Multivariable regression and lagged multilevel regression examined associations between self-reported sight loss and depression and anxiety. Depression symptoms mean ranged from 2.2 (±3.2) for those with excellent eyesight to 5.9 (±5.4) for those with poor/legally blind in Wave 1, with similar increases observed across all six waves. Adjusted lagged regression analyzes demonstrated that sight loss independently predicted worsening depressive symptoms (poor eyesight: β = 0.44, 95%CI 0.11-0.78) and anxiety scores (poor eyesight: β = 0.36, 95%CI 0.02-0.70) at subsequent waves. Sight loss prospectively worsens depression and anxiety symptoms, independent of prior symptom severity. Integrating proactive psychological assessment and continuous support, is essential to reduce worsening depression and anxiety.
- 11 November 2026
- Published by Taylor & Francis in Aging & Mental Health
- p. 1-13
Sight loss is associated with worsening depressive and anxiety symptoms among older adults: evidence from the Irish longitudinal study on ageing
Sight loss is associated with adverse mental health conditions among aging populations. The extent of which sight loss worsens depression or anxiety in those with existing or at an elevated risk is unknown. This study aims to examine whether sight loss prospectively predicts progression/worsening of depression and anxiety. A longitudinal secondary analysis of The Irish Longitudinal Study of Ageing (TILDA) was conducted. Outcomes for anxiety and depression were measured through the self-reported Centre for Epidemiological Studies Depression Scale and the Hospital Anxiety and Depression-Anxiety subscale. Multivariable regression and lagged multilevel regression examined associations between self-reported sight loss and depression and anxiety. Depression symptoms mean ranged from 2.2 (±3.2) for those with excellent eyesight to 5.9 (±5.4) for those with poor/legally blind in Wave 1, with similar increases observed across all six waves. Adjusted lagged regression analyzes demonstrated that sight loss independently predicted worsening depressive symptoms (poor eyesight: β = 0.44, 95%CI 0.11-0.78) and anxiety scores (poor eyesight: β = 0.36, 95%CI 0.02-0.70) at subsequent waves. Sight loss prospectively worsens depression and anxiety symptoms, independent of prior symptom severity. Integrating proactive psychological assessment and continuous support, is essential to reduce worsening depression and anxiety.
- Open Access
- 28 May 2025
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 195, 112166
Effective maNagement of depression among patients witH cANCEr (ENHANCE): A hybrid systematic review and (attempted) network meta-analysis of randomized controlled trials
- 28 May 2025
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 195, 112166
Open AccessEffective maNagement of depression among patients witH cANCEr (ENHANCE): A hybrid systematic review and (attempted) network meta-analysis of randomized controlled trials
- Open Access
- 17 March 2025
- Published by Springer Nature in Medical Science Educator
- Vol. 35 (3) , 1787-1801
Lifestyle Medicine Pillars and Pedagogies in Pre-registration Health Profession Degrees: A Scoping Review
Non-communicable diseases are the greatest cause of mortality and disability globally. Lifestyle medicine (LM) can facilitate effective prevention and treatment of such diseases. However, the extent and nature of LM education has not been sufficiently mapped. This scoping review aimed to assess the pedagogies, content and structure of LM education in pre-registration health profession degrees using the JBI methodology. Fifty-two articles met the inclusion criteria. Three of the six core LM pillars were not taught in the majority of programmes studied. Universities should survey their curricula to identify such gaps and appropriate opportunities to incorporate these pillars into existing modules.
- 17 March 2025
- Published by Springer Nature in Medical Science Educator
- Vol. 35 (3) , 1787-1801
Open AccessLifestyle Medicine Pillars and Pedagogies in Pre-registration Health Profession Degrees: A Scoping Review
Non-communicable diseases are the greatest cause of mortality and disability globally. Lifestyle medicine (LM) can facilitate effective prevention and treatment of such diseases. However, the extent and nature of LM education has not been sufficiently mapped. This scoping review aimed to assess the pedagogies, content and structure of LM education in pre-registration health profession degrees using the JBI methodology. Fifty-two articles met the inclusion criteria. Three of the six core LM pillars were not taught in the majority of programmes studied. Universities should survey their curricula to identify such gaps and appropriate opportunities to incorporate these pillars into existing modules.
- Open Access
- 12 November 2022
- Published by Springer Nature in Systematic Reviews
- Vol. 11 (1) , 1-12
Effective maNagement of depression among patients witH cANCEr (ENHANCE): a protocol for a hybrid systematic review and network meta-analysis of randomised controlled trials of interventions for depressive symptoms
Background: Depression is common among patients with cancer and is associated with lower treatment participation, lower satisfaction with care, poorer quality of life, greater symptom burden and higher healthcare costs. Various types of interventions (e.g. pharmacological, psychotherapy) are used for the treatment of depression. However, evidence for these among patients with cancer is limited. Furthermore, the relative effectiveness and acceptability of different approaches are unknown because a direct comparison between all available treatments has not been carried out. We will address this by conducting a network meta-analysis (NMA) of interventions for depression among people with cancer using a hybrid overview of reviews and systematic review methodology. Methods: We will search for and extract data from systematic reviews of randomised controlled trials (RCTs) of depression interventions for patients with cancer from inception, before performing a supplemental search for more recent RCTs. We will include RCTs comparing pharmacological, psychotherapy, exercise, combination therapy, collaborative care or complementary and alternative medicine interventions with pill placebo, no treatment, waitlist, treatment as usual or minimal treatment control groups, or directly in head-to-head trials, among adults who currently have cancer or have a history of any cancer and elevated depressive symptoms (scores above a cut-off on validated scales or meeting diagnostic criteria). Our primary outcomes will be change in depressive symptoms (standardised mean difference) and intervention acceptability (% who withdrew). Our secondary outcomes will be 6-month change in depressive symptoms, health-related quality of life, adverse events and mortality. We will independently screen for eligibility, extract data and assess risk of bias using the RoB 2 tool. We will use frequentist random-effects multivariate NMA in Stata, rankograms and surface under the cumulative ranking curves to synthesise evidence and obtain a ranking of intervention groups. We will explore heterogeneity and inconsistency using local and global measures and evaluate the credibility of results using the Confidence in NEtwork Meta-Analysis (CINeMA) framework. Discussion: Our findings will provide the best available evidence for managing depression among patients with cancer. Such information will help to inform clinical guidelines, evidence-based treatment decisions and future research by identifying gaps in the current literature. Systematic review registration: Submitted to PROSPERO (record number: 290145), awaiting registration.
- 12 November 2022
- Published by Springer Nature in Systematic Reviews
- Vol. 11 (1) , 1-12
Open AccessEffective maNagement of depression among patients witH cANCEr (ENHANCE): a protocol for a hybrid systematic review and network meta-analysis of randomised controlled trials of interventions for depressive symptoms
Background: Depression is common among patients with cancer and is associated with lower treatment participation, lower satisfaction with care, poorer quality of life, greater symptom burden and higher healthcare costs. Various types of interventions (e.g. pharmacological, psychotherapy) are used for the treatment of depression. However, evidence for these among patients with cancer is limited. Furthermore, the relative effectiveness and acceptability of different approaches are unknown because a direct comparison between all available treatments has not been carried out. We will address this by conducting a network meta-analysis (NMA) of interventions for depression among people with cancer using a hybrid overview of reviews and systematic review methodology. Methods: We will search for and extract data from systematic reviews of randomised controlled trials (RCTs) of depression interventions for patients with cancer from inception, before performing a supplemental search for more recent RCTs. We will include RCTs comparing pharmacological, psychotherapy, exercise, combination therapy, collaborative care or complementary and alternative medicine interventions with pill placebo, no treatment, waitlist, treatment as usual or minimal treatment control groups, or directly in head-to-head trials, among adults who currently have cancer or have a history of any cancer and elevated depressive symptoms (scores above a cut-off on validated scales or meeting diagnostic criteria). Our primary outcomes will be change in depressive symptoms (standardised mean difference) and intervention acceptability (% who withdrew). Our secondary outcomes will be 6-month change in depressive symptoms, health-related quality of life, adverse events and mortality. We will independently screen for eligibility, extract data and assess risk of bias using the RoB 2 tool. We will use frequentist random-effects multivariate NMA in Stata, rankograms and surface under the cumulative ranking curves to synthesise evidence and obtain a ranking of intervention groups. We will explore heterogeneity and inconsistency using local and global measures and evaluate the credibility of results using the Confidence in NEtwork Meta-Analysis (CINeMA) framework. Discussion: Our findings will provide the best available evidence for managing depression among patients with cancer. Such information will help to inform clinical guidelines, evidence-based treatment decisions and future research by identifying gaps in the current literature. Systematic review registration: Submitted to PROSPERO (record number: 290145), awaiting registration.
- Open Access
- 20 December 2021
- Published by Springer Nature in Research Square
Effective maNagement of Depression among Patients witH cANCEr (ENHANCE): A Protocol for a Hybrid Systematic Review and Network Meta-Analysis of Randomized Controlled Trials of Interventions for Depressive Symptoms.
Background: Depression is common among patients with cancer and is associated with lower treatment participation, lower satisfaction with care, poorer quality of life, greater symptom burden, and higher healthcare costs. Various types of interventions (e.g., pharmacological, psychotherapy) are used for the treatment of depression. However, evidence for these among patients with cancer is limited. Furthermore, the relative effectiveness and acceptability of different approaches is unknown because a direct comparison between all available treatments has not been carried out. We will address this by conducting a network meta-analysis (NMA) of interventions for depression among people with cancer using a hybrid overview of reviews and systematic review methodology. Methods: We will search for and extract data from systematic reviews of randomised controlled trials (RCTs) of depression interventions for patients with cancer from inception, before performing a supplemental search for more recent RCTs. We will include RCTs comparing pharmacological, psychotherapy, exercise, combination therapy, collaborative care, or complementary and alternative medicine interventions with pill placebo, no treatment, waitlist, treatment as usual, or minimal treatment control groups, or directly in head-to-head trials, among adults who have a current or previous diagnosis of cancer and elevated depressive symptoms (scores above a cut-off on validated scales or meeting diagnostic criteria). Our primary outcomes will be change in depressive symptoms (standardised mean difference) and intervention acceptability (% who withdrew). Our secondary outcomes will be 6-month change in depressive symptoms, health-related quality of life, adverse events and mortality. We will independently screen for eligibility, extract data, and assess risk of bias using the RoB2 tool. We will use frequentist random-effects multivariate NMA in Stata, Rankograms and surface under the cumulative ranking curves to synthesize evidence and obtain a ranking of intervention groups. We will explore heterogeneity and inconsistency using local and global measures and evaluate the credibility of results using the Confidence in NEtwork Meta-Analysis (CINeMA) framework.Discussion: Our findings will provide the best available evidence for managing depression among patients with cancer. Such information will help to inform clinical guidelines, evidence-based treatment decisions and future research by identifying gaps in the current literature. Systematic review registration: Submitted to PROSPERO (record number: 290145), awaiting registration
- 20 December 2021
- Published by Springer Nature in Research Square
Open AccessEffective maNagement of Depression among Patients witH cANCEr (ENHANCE): A Protocol for a Hybrid Systematic Review and Network Meta-Analysis of Randomized Controlled Trials of Interventions for Depressive Symptoms.
Background: Depression is common among patients with cancer and is associated with lower treatment participation, lower satisfaction with care, poorer quality of life, greater symptom burden, and higher healthcare costs. Various types of interventions (e.g., pharmacological, psychotherapy) are used for the treatment of depression. However, evidence for these among patients with cancer is limited. Furthermore, the relative effectiveness and acceptability of different approaches is unknown because a direct comparison between all available treatments has not been carried out. We will address this by conducting a network meta-analysis (NMA) of interventions for depression among people with cancer using a hybrid overview of reviews and systematic review methodology. Methods: We will search for and extract data from systematic reviews of randomised controlled trials (RCTs) of depression interventions for patients with cancer from inception, before performing a supplemental search for more recent RCTs. We will include RCTs comparing pharmacological, psychotherapy, exercise, combination therapy, collaborative care, or complementary and alternative medicine interventions with pill placebo, no treatment, waitlist, treatment as usual, or minimal treatment control groups, or directly in head-to-head trials, among adults who have a current or previous diagnosis of cancer and elevated depressive symptoms (scores above a cut-off on validated scales or meeting diagnostic criteria). Our primary outcomes will be change in depressive symptoms (standardised mean difference) and intervention acceptability (% who withdrew). Our secondary outcomes will be 6-month change in depressive symptoms, health-related quality of life, adverse events and mortality. We will independently screen for eligibility, extract data, and assess risk of bias using the RoB2 tool. We will use frequentist random-effects multivariate NMA in Stata, Rankograms and surface under the cumulative ranking curves to synthesize evidence and obtain a ranking of intervention groups. We will explore heterogeneity and inconsistency using local and global measures and evaluate the credibility of results using the Confidence in NEtwork Meta-Analysis (CINeMA) framework.Discussion: Our findings will provide the best available evidence for managing depression among patients with cancer. Such information will help to inform clinical guidelines, evidence-based treatment decisions and future research by identifying gaps in the current literature. Systematic review registration: Submitted to PROSPERO (record number: 290145), awaiting registration
- Open Access
- 13 August 2019
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 10, 1801
Caregiver Choice and Caregiver Outcomes: A Longitudinal Study of Irish Spousal Dementia Caregivers
Background: The perception of choice in becoming a caregiver may impact on caregiver psychological and physical health. We determined the proportion of spousal dementia caregivers who felt they had a choice, and examined whether lack of choice in taking up the caregiving role and the perceived degree of choice in caregiving predicted caregiver health and wellbeing and care-recipient placement in long-term care at 1-year follow-up. Methods: We performed secondary analyses of data from DeStress, a longitudinal study of 251 spousal dementia caregivers in Ireland. We used multivariate logistic and linear regression analyses to examine whether lack of choice (a dichotomous item) and/or the perceived degree of choice (a 9-point scale) at baseline predicted caregiver health (number of chronic health conditions; self-reported health) and wellbeing (e.g., burden, anxiety, depression, stress, and positive aspects of caregiving) and care status (continued care at home or placement in long-term care) at follow-up. Results: The vast majority of caregivers (82%) reported that they had no choice in taking up the caregiving role. Nevertheless, nearly three-quarters (74%) responded above the midpoint on the rating scale (Mean = 6.82, SD = 3.22; Median = 9; Mode = 9), indicating they provided care voluntarily. Caregivers who reported a greater degree of choice were more likely to still be providing care at home at follow-up and to identify benefits from providing care. Neither choice nor degree of choice predicted any other caregiver outcomes. Conclusion: For the vast majority of spousal dementia caregivers, taking up the caregiving role is not perceived as a choice; yet, most report performing this role voluntarily. Thus, facilitating greater choice may not necessarily diminish the key contribution family caregivers make to the care system. Although we found no evidence that caregiver choice predicted more positive caregiver health and wellbeing, the perception of choice is important in and of itself, and may benefit caregivers by facilitating the identification of positive aspects of care and be a factor in delaying care-recipient placement in long-term care. Future research should be especially mindful of how caregiver choice is assessed and how this may affect the resulting prevalence of choice.
- 13 August 2019
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 10, 1801
Open AccessCaregiver Choice and Caregiver Outcomes: A Longitudinal Study of Irish Spousal Dementia Caregivers
Background: The perception of choice in becoming a caregiver may impact on caregiver psychological and physical health. We determined the proportion of spousal dementia caregivers who felt they had a choice, and examined whether lack of choice in taking up the caregiving role and the perceived degree of choice in caregiving predicted caregiver health and wellbeing and care-recipient placement in long-term care at 1-year follow-up. Methods: We performed secondary analyses of data from DeStress, a longitudinal study of 251 spousal dementia caregivers in Ireland. We used multivariate logistic and linear regression analyses to examine whether lack of choice (a dichotomous item) and/or the perceived degree of choice (a 9-point scale) at baseline predicted caregiver health (number of chronic health conditions; self-reported health) and wellbeing (e.g., burden, anxiety, depression, stress, and positive aspects of caregiving) and care status (continued care at home or placement in long-term care) at follow-up. Results: The vast majority of caregivers (82%) reported that they had no choice in taking up the caregiving role. Nevertheless, nearly three-quarters (74%) responded above the midpoint on the rating scale (Mean = 6.82, SD = 3.22; Median = 9; Mode = 9), indicating they provided care voluntarily. Caregivers who reported a greater degree of choice were more likely to still be providing care at home at follow-up and to identify benefits from providing care. Neither choice nor degree of choice predicted any other caregiver outcomes. Conclusion: For the vast majority of spousal dementia caregivers, taking up the caregiving role is not perceived as a choice; yet, most report performing this role voluntarily. Thus, facilitating greater choice may not necessarily diminish the key contribution family caregivers make to the care system. Although we found no evidence that caregiver choice predicted more positive caregiver health and wellbeing, the perception of choice is important in and of itself, and may benefit caregivers by facilitating the identification of positive aspects of care and be a factor in delaying care-recipient placement in long-term care. Future research should be especially mindful of how caregiver choice is assessed and how this may affect the resulting prevalence of choice.
- Open Access
- 9 January 2017
- Published by Elsevier in International Psychogeriatrics
- Vol. 29 (4) , 615-625
Cognitive reserve and self-efficacy as moderators of the relationship between stress exposure and executive functioning among spousal dementia caregivers
- 9 January 2017
- Published by Elsevier in International Psychogeriatrics
- Vol. 29 (4) , 615-625
Open AccessCognitive reserve and self-efficacy as moderators of the relationship between stress exposure and executive functioning among spousal dementia caregivers
- 11 June 2015
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 28 (4) , 260-271
Risk of Cognitive and Functional Impairment in Spouses of People With Dementia
Caring for a spouse with dementia is a chronic stressor that may compromise caregivers’ own cognitive functioning and capacity to provide adequate care. We examined whether having (i) a spouse with dementia and (ii) a spouse who requires assistance with activities of daily living predicted cognitive and functional impairments in respondents to the Health and Retirement Study (n = 7965). Respondents who had a spouse who requires care had poorer cognitive functioning, whereby this relationship was significantly stronger for male respondents. Having a spouse with dementia moderated the relationship between income and cognition and predicted caregiver functional impairment, though not when depression was controlled. Although we found no significant differences on any individual cognitive domains between 179 dementia caregivers and sociodemographically matched noncaregivers, our findings suggest that caregivers, especially men, and low-income individuals who have a spouse with dementia are more vulnerable to adverse cognitive outcomes. Targeting depression in spouses of people with dementia may help to prevent functional impairments.
- 11 June 2015
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 28 (4) , 260-271
Risk of Cognitive and Functional Impairment in Spouses of People With Dementia
Caring for a spouse with dementia is a chronic stressor that may compromise caregivers’ own cognitive functioning and capacity to provide adequate care. We examined whether having (i) a spouse with dementia and (ii) a spouse who requires assistance with activities of daily living predicted cognitive and functional impairments in respondents to the Health and Retirement Study (n = 7965). Respondents who had a spouse who requires care had poorer cognitive functioning, whereby this relationship was significantly stronger for male respondents. Having a spouse with dementia moderated the relationship between income and cognition and predicted caregiver functional impairment, though not when depression was controlled. Although we found no significant differences on any individual cognitive domains between 179 dementia caregivers and sociodemographically matched noncaregivers, our findings suggest that caregivers, especially men, and low-income individuals who have a spouse with dementia are more vulnerable to adverse cognitive outcomes. Targeting depression in spouses of people with dementia may help to prevent functional impairments.
- 1 November 2013
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 34, 108-119
C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy
- 1 November 2013
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 34, 108-119
C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy
- 26 August 2013
- Published by Taylor & Francis in Psychology & Health
- Vol. 29 (2) , 141-161
‘I’m not complaining because I’m alive’: Barriers to the emergence of a discourse of cancer-related fatigue
Cancer-related fatigue (CRF) is a potentially chronic condition that is inadequately discussed, diagnosed and treated. This study examined the factors that contribute to the absence of a discourse of CRF. A thematic discourse analysis was carried out on the 'additional comments' left by 73 fatigued cancer patients and survivors as part of a questionnaire study on CRF. The findings indicated that conflict between patients' own conceptualisations of CRF and those of family/friends and/or medical professionals hampers social and medical dialogue of CRF. Fatigue forms a part of patients' ongoing cancer identity even after cancer treatment has been completed; however, because of the dominance of wider social discourses on recovery from illness and cancer survivorship, others fail to recognise individual narratives of CRF when these deviate from or oppose such established discourses. Furthermore, the development of a discourse of CRF is actively obstructed because the enormity of cancer invalidates and overshadows patients' postcancer experiences. 'Additional comments' are a rich source of data that can give insight into issues facing patients. Beyond the lack of recognition, support and interventions available for CRF, broader discourses of health, illness and cancer hamper communication regarding this side effect.
- 26 August 2013
- Published by Taylor & Francis in Psychology & Health
- Vol. 29 (2) , 141-161
‘I’m not complaining because I’m alive’: Barriers to the emergence of a discourse of cancer-related fatigue
Cancer-related fatigue (CRF) is a potentially chronic condition that is inadequately discussed, diagnosed and treated. This study examined the factors that contribute to the absence of a discourse of CRF. A thematic discourse analysis was carried out on the 'additional comments' left by 73 fatigued cancer patients and survivors as part of a questionnaire study on CRF. The findings indicated that conflict between patients' own conceptualisations of CRF and those of family/friends and/or medical professionals hampers social and medical dialogue of CRF. Fatigue forms a part of patients' ongoing cancer identity even after cancer treatment has been completed; however, because of the dominance of wider social discourses on recovery from illness and cancer survivorship, others fail to recognise individual narratives of CRF when these deviate from or oppose such established discourses. Furthermore, the development of a discourse of CRF is actively obstructed because the enormity of cancer invalidates and overshadows patients' postcancer experiences. 'Additional comments' are a rich source of data that can give insight into issues facing patients. Beyond the lack of recognition, support and interventions available for CRF, broader discourses of health, illness and cancer hamper communication regarding this side effect.